Junhui Fu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Liver physiology and pathology
Papers in
- Surgery 13
- Esophageal Cancer Research and Treatment 9
- Esophageal and GI Pathology 4
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Gastric Cancer Management and Outcomes 3
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Chunlei Dai (2 shared papers)Yanting Zhang (1 shared paper)Zhongxian Yang (1 shared paper)Fuxiang Yu (2 shared papers)Qiyu Zhang (2 shared papers)Li Wang (1 shared paper)Ganfeng Luo (1 shared paper)Ke Li (1 shared paper)
In The Last Decade
Junhui Fu
27 papers receiving 405 citations
Junhui Fu's Hit Papers
Peers
Comparison fields: 5 of 48
- Cancer Research 75
- Hepatology 37
- Surgery 197
- Genetics 23
- Oncology 54
Countries citing papers authored by Junhui Fu
This map shows the geographic impact of Junhui Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Fu more than expected).
Fields of papers citing papers by Junhui Fu
This network shows the impact of papers produced by Junhui Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Fu. The network helps show where Junhui Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junhui Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma ( NIC‐ESCC2019 ): A multicenter, phase 2 study Hit paper breakdown → | 2022 | 121 |
| 2 | 2020 | 60 | |
| 3 | 2013 | 47 | |
| 4 | 2014 | 30 | |
| 5 | 2022 | 23 | |
| 6 | 2018 | 23 | |
| 7 | AK001058 promotes the proliferation and migration of colorectal cancer cells by regulating methylation of ADAMTS12. | 2019 | 13 |
| 8 | 2014 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2017 | 12 | |
| 11 | Long non-coding RNA AK001058 regulates tumor growth and angiogenesis in colorectal cancer via methylation of ADAMTS12. | 2019 | 11 |
| 12 | 2022 | 5 | |
| 13 | 2024 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2017 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2009 | 3 | |
| 20 | 2024 | 3 |
About Junhui Fu
Junhui Fu is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Hepatology, having authored 30 papers that have together received 409 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (9 papers), Esophageal and GI Pathology (4 papers), Circular RNAs in diseases (3 papers), Gastric Cancer Management and Outcomes (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Liver physiology and pathology (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (75 citations), Hepatology (37 citations), Surgery (197 citations), Genetics (23 citations) and Oncology (54 citations). Junhui Fu has collaborated with scholars based in China, Hong Kong and Taiwan. Frequent co-authors include Chunlei Dai, Yanting Zhang, Zhongxian Yang, Fuxiang Yu, Qiyu Zhang, Li Wang, Ganfeng Luo, Ke Li, Yang Wang and Wan Qing li. Their work appears in journals such as Journal of Immunotherapy, Cancer Cell International, Frontiers in Oncology, The Annals of Thoracic Surgery and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.